Video & Transcript Research : 'ibogaine-based therapeutics'
Page 1 of 500
OK
Transcript Highlights:
- We have a new director, and this model is based on what's being done in Arkansas.
- So it's been changed to where it's reasonable now, and it's based on another state's model, which works
- currently going to Mexico for this treatment I began is let me back up to explain what I began is ibogaine
Keywords:
Oklahoma Health Care Authority, Medicaid, immigration verification, healthcare access, federal reporting, health care providers, auditing, patient rights, claims, protection from fraud, audit process, error correction, hospice care, physician determination, healthcare standards, symptom management, health information exchange, all-payer claims database, health care transparency, health care costs
OK
Oklahoma 2026 Regular Session
Health and Human Services Oversight REVISION 2: Delayed until 11:30 AM
Health and Human Services Oversight
Transcript Highlights:
- This legislation creates a vehicle for ibogaine, which is a medication that they're developing, deals
- So moving to a fee-based system... ...crime.
- So moving to a fee-based system with a revolving fund is the way we're trying to go about it.
Bills:
HB2947, HB2964, HB3143, HB3144, HB3342, HB3344, HB3519, HB3522, HB3530, HB3645, HB3647, HB3834, HB4300, HB4422, HB4423
Keywords:
behavioral health, Medicaid expansion, clinical interns, mental health services, licensing requirements, medical records, patient rights, privacy, fees, healthcare access, legal claims, medical marijuana, license transfer, Oklahoma Medical Marijuana Authority, moratorium, business regulation, commercial grower licenses, licensing restrictions, agriculture, Medicaid
OK
Transcript Highlights:
- this because they've got to go in and figure out how many members would be eligible, and it's all based
Bills:
HB2947, HB3257, HB3264, HB3834, HB3940, HB3944, HB3979, HB4003, HB4118, HB4326, HB4346, HB4421
Keywords:
behavioral health, Medicaid expansion, clinical interns, mental health services, licensing requirements, veterans, disability benefits, federal law, Oklahoma Statutes, military service, criminal justice, minimum sentences, parole eligibility, violent crimes, Oklahoma statutes, HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs
OK
Oklahoma 2026 Regular Session
Health and Human Services REVISED Apr 13th, 2026 at 02:00 pm
Health and Human Services
Transcript Highlights:
- In addition to that, I think he got his start in medicine at an air force base if I'm not mistaken and
Bills:
HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647
Keywords:
controlled dangerous substances, controlled substances, drug scheduling, Schedule I, Schedule IV, anti-drug diversion, drug diversion, synthetic opioids, fentanyl analogs, designer drugs, synthetic cannabinoids, benzodiazepines, benzodiazepine analogs, opioids, hallucinogens, depressants, pharmacy regulation, narcotics control, Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, DEA scheduling
OK
Oklahoma 2026 Regular Session
Health and Human Services REVISED Apr 13th, 2026
Health and Human Services
Transcript Highlights:
- Chairman, if it'd be okay with you, we have Nate Morgan for Americans for Ibogaine here.
- Your question was the effects of ibogaine or the cost? No, I didn't know.
- I took ibogaine under medicalized supervision from doctors, nurses, and paramedics.
- I understand— ...legislation and Americans for Ibogaine. I understand.
- So from what I understand, not everyone is a candidate for Ibogaine therapy.
Bills:
HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647
Keywords:
controlled dangerous substances, controlled substances, drug scheduling, Schedule I, Schedule IV, anti-drug diversion, drug diversion, synthetic opioids, fentanyl analogs, designer drugs, synthetic cannabinoids, benzodiazepines, benzodiazepine analogs, opioids, hallucinogens, depressants, pharmacy regulation, narcotics control, Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, DEA scheduling
Summary:
The Senate Health and Human Services Committee first considered three executive nominations. Shonda Lasseter was reappointed to the State Board of Pharmacy, with discussion focused on pharmacy staffing shortages, PBMs, and broader health care workforce challenges; she was advanced 11-0. Dr. Lane Sabara was renominated to the Health Care Workforce Training Commission, where members discussed rural physician shortages and training pipelines; he was advanced 12-0. Dr. Paul Wright was nominated to fill an unexpired term on the same commission and was advanced 12-0 after questions about his availability and experience supporting rural medicine.
The committee then heard several health-related bills. HB 3767, which adds 14 chemicals used to enhance fentanyl to Oklahoma’s controlled substances schedules, advanced 10-0. HB 3934, a dentistry workforce and cleanup bill updating insurance-claim and billing language, advanced 11-0. HB 4199, creating a three-year tri-share workforce pilot program for the Department of Commerce, was amended to change eligibility language and then advanced 9-2. HB 2947, allowing supervised behavioral health interns to bill Medicaid, advanced 10-1. HB 3834, authorizing the Department of Health to begin stage-one clinical trials for ibogaine and creating a revolving fund for that purpose, drew extensive testimony about veteran and first responder treatment, safety, funding, and state liability, and advanced 10-2.
Additional measures also moved forward. HB 4302, after amendment, advanced 12-0 on a juvenile oversight reporting and law enforcement notification issue. Committee member bills included HB 495, reinstating the 211 Collaborative advisory council, which advanced 11-0; HB 3287, requiring domestic violence and human trafficking signage in health facilities, which advanced 11-0; HB 3649, allowing the Mental Health Department to sell underused property and keep the proceeds in its trust, which advanced 12-0 after amendment; HB 4430, clarifying malpractice coverage for APRNs and PAs at state facilities, which advanced 12-0; HB 2059, creating a mechanism to reimburse medication costs for incarcerated people in county and municipal jails, which advanced 12-0 after questions about continuity of care; and HB 3647, creating an all-payer claims database and transparency board, which advanced 10-2. The committee adjourned after announcing another meeting the following week.
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 22nd, 2026 at 01:30 pm
Oklahoma Senate Floor Meeting
Transcript Highlights:
- Contract attorneys are compensated based on the hours they serve, and so it would be from some other
Bills:
HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339
Keywords:
HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 22nd, 2026
Oklahoma Senate Floor Meeting
Transcript Highlights:
- That contract attorney is based upon the hours they serve.
- That contract attorney is based upon the hours they serve.
Bills:
HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339
Keywords:
HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing
Summary:
The Senate convened with a quorum, heard an invocation, and recognized several guests and groups in the gallery, including the Ponca City High School Poe High Steppers, the Edmond Democratic Women, family members of senators, a Grace Reform Baptist Church co-op group, and Oklahoma 4-H participants. The chamber also honored the Red Oak Lady Eagles state championship basketball team with a citation and remarks celebrating their first school basketball title and strong season.
The Senate adopted Senate Concurrent Resolution 22, supporting the Lights Out Oklahoma campaign to reduce bird mortality during migration by encouraging reduced exterior lighting in peak migration months. The chamber also adopted Senate Resolution 41, proclaiming April 22, 2026, as the 27th annual 4-H Day at the Capitol, with testimony from 4-H representatives emphasizing youth leadership, civic engagement, and workforce readiness.
Several bills passed, including House Bill 169 (house amendments adopted and the bill passed as an emergency measure), House Bill 2123 on the Arkansas River bridge, House Bill 2650 on summary administration estate thresholds, House Bill 3260 on funeral director continuing education approvals, House Bill 3403 on a DEQ/OSU sewage sludge pilot study, House Bill 3649 on the Mental Health Department real property trust, House Bill 3742 on criminal discovery, House Bill 3831 on a Task Force One revolving fund, House Bill 3996 on indigent defense experts in capital cases, House Bill 4321 on limits on retroactive building rule application, and House Bill 4339 on summary administration notice timing. House Bill 1047, which would have authorized a tribal sports betting framework and related revenue distributions, drew extensive debate over gambling addiction, revenue, tribal compacts, geofencing, and NIL funding, but failed 21-27; Senator Coleman gave notice of intent to reconsider. The Senate then announced an Appropriations Committee meeting and adjourned until the next scheduled session.
MO
Missouri 2026 Regular Session
Emerging Issues Feb 16th, 2026
Emerging Issues and Professional Registration
Transcript Highlights:
- Ibogaine is a naturally occurring alkaloid. Ibogaine is a naturally occurring alkaloid.
- of ibogaine.
- because of ibogaine.
- It's not based on public health.
- It's not based on public health.
Summary:
The committee first met in executive session and voted do pass on House Bill 3037, House Bill 2760, House Bill 1778, and House Bill 2830, each by recorded roll call. HB 3037, HB 2760, and HB 1778 all passed 8-4, while HB 2830 passed unanimously 12-0. The committee also said it would not take up HB 1746 and HB 1769 yet, because more work was needed on an amendment.
The public hearing began with House Bill 3005, sponsored by Representative Justice, which would require public and school libraries to adopt and post reconsideration policies for challenged materials, limit requests to local residents or parents/guardians, extend the process to digital materials, and prohibit tracking or retaining personalized user data from digital library resources. Justice said the bill was developed with the Secretary of State’s office and library groups and was intended to add transparency, local control, and privacy protections. Testimony from EBSCO Information Services and the Missouri Library Association supported the bill as a codification of existing library practices and a way to create clearer procedures.
The committee then heard a group of similar bills on AI-generated or digitally altered depictions, including measures by Representatives Lucas, Farnan, Gallick, Schmidt, Williams, Houseman, and Dolan. The sponsors described the bills as closing loopholes in child pornography, revenge-porn, and digital impersonation laws, creating civil remedies, criminal penalties, and in some versions platform takedown requirements for nonconsensual altered images. Members raised questions about how to combine the bills, whether sunsets should be included, and how the proposals relate to existing revenge-porn law. No votes were taken on these bills during the hearing.
Finally, the committee heard House Bills 2817 and 2961 on ibogaine research for veterans and other trauma-affected populations, followed by House Bills 1717 and 1643 on psilocybin and other alternative therapies. Supporters, including veterans, first responders, clinicians, and family members, described severe PTSD, TBI, addiction, and suicide crises and said these treatments had helped them when conventional care had not. Opponents, including the Missouri State Medical Association, said they did not support non-FDA-approved drugs. Members questioned the cost and structure of the proposed studies, the role of the FDA, and whether similar research is already underway. The hearing ended without a vote on these bills.
TX
Transcript Highlights:
- At the top line, the study showed that there was a remarkable therapeutic efficacy of Ibogaine after
- Investigation in Texas calls for a rigorous evidence-based exploration of Ibogaine as a prescribable
- Ibogaine.
- I believe that the only ibogaine that's available right now is the semi-synthetic, from plant-based extraction
- Prior to the testimony today, I was under the impression that the only ibogaine we had was plant-based
Bills:
HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246
Keywords:
HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care
Summary:
The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.
TX
Texas 89th Regular
Senate Committee on Health and Human Services (Part II) Apr 23rd, 2025
Health & Human Services
Transcript Highlights:
- Ibogaine has significant therapeutic value. It has no propensity for abuse.
- But no one's ever heard of Ibogaine or Ibogaine raves. because there is no recreational.
- Ibogaine has helped these veterans? Absolutely. So.
- Mexico to undergo Ibogaine treatments.
- reason to believe that with proper... drug development research that there will be the development of Ibogaine-based
Bills:
SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583
Keywords:
hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements
MO
Transcript Highlights:
- Ibogaine is a naturally occurring alkaloid.
- One's on psilocybin and one's on ibogaine.
- of ibogaine.
- And so that's why I've done ibogaine, because ibogaine tends to work a little better for brain injuries
- It's not based on public health.
Summary:
The committee first met in executive session and voted do pass on House Bills 3037, 2760, 1778, and 2830, each by recorded roll call. HB 3037, HB 2760, and HB 1778 all passed 8-4, while HB 2830 passed unanimously 12-0. The committee also noted that HB 1746 and HB 1769 would not be taken up that night because more work was needed on an amendment.
The public hearing then focused on HB 3005, which would require public libraries and school districts to adopt and post reconsideration policies for challenged materials, limit who may file requests to local residents or parents/guardians, extend the process to digital materials, and protect user privacy by prohibiting tracking of individualized digital library use. Representative Justice said the bill was developed with library and state officials and was intended to codify existing practices with added guardrails. Testimony from EBSCO Information Services and the Missouri Library Association supported the bill as a transparent, community-based process.
The committee next heard seven similar bills dealing with AI-generated or digitally altered depictions, including child sexual abuse material, nonconsensual intimate images, and digital impersonation. Sponsors described the bills as closing loopholes in current law, creating criminal penalties and civil remedies, and in some versions requiring platforms to remove content quickly. Members asked about combining the bills, whether sunsets should be considered, and how the proposals related to existing revenge-porn laws. No testimony in opposition was offered during the hearing.
The final hearings centered on HB 2817/HB 2961 and HB 1717/HB 1643, which proposed state-supported research and expanded access frameworks for ibogaine and psilocybin, respectively, aimed largely at veterans, first responders, and others with PTSD, traumatic brain injury, addiction, and depression. Supporters offered extensive personal testimony about treatment-resistant conditions, suicide risk, and reported benefits from psychedelic-assisted treatment, while the Missouri State Medical Association opposed the ibogaine proposal because it involves non-FDA-approved drugs. Members questioned costs, FDA oversight, state expertise, and whether the research should be limited or include sunsets, but no votes were taken on the public hearing bills.
AZ
Arizona 2026 Regular Session
01/06/2026 - Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies
Transcript Highlights:
- Suicidal ideation with ibogaine.
- So why ibogaine?
- Why ibogaine?
- In my own words, this is what ibogaine does.
- "I'm going to assume that drugs like ibogaine...
Summary:
The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place.
Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur.
Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.
TX
Texas 89th Regular
Press Conference: HB 3717 - Texas Ibogaine Initiative Mar 18th, 2025
Texas House Floor Meeting
Transcript Highlights:
- My name is Brian Hubbard, and I am the executive director of the American Ibogaine Initiative, brought
- That number is much larger—seeking Ibogaine-assisted therapy.
- The scientific evidence supporting these emerging therapeutics continues to expand.
- Prime, are there any other conditions that ibogaine has shown some effectiveness in treating?
- However, recent events have demonstrated that ibogaine possesses...
Summary:
The meeting was a Texas Capitol press event in support of House Bill 3717, which would advance ibogaine research and create a public-private pathway to move the treatment toward FDA approval. Speakers included Brian Hubbard of the American Ibogaine Initiative, Rep. Cody Harris, and VETS co-founders Marcus and Amber Capone. They framed the bill as a chance for Texas to lead on treatment for opioid use disorder, PTSD, traumatic brain injury, and other “diseases of despair,” especially among veterans and their families.
Testimony focused heavily on the veteran suicide crisis and personal stories of loss and recovery. Marcus Capone described his Navy SEAL service and said conventional treatments had not been enough for many veterans, while Amber Capone cited VETS’ support for roughly 1,000 veterans and a Stanford collaboration that she said showed large reductions in PTSD, anxiety, depression, and suicidality after ibogaine treatment. Supporters also argued ibogaine may have broader applications, including for other substance use disorders and some neurological conditions, and emphasized the need for research, supervised clinical use, and insurance coverage.
No formal committee vote or legislative action was taken in the transcript. The event ended with a brief Q&A and a call for Texas legislators to support HB 3717 and help move the bill forward.
KY
Kentucky 2025 Regular Session
Interim Joint Committee on Health Services (8-27-25)
Transcript Highlights:
- </c> which is based out of Cumberland Health. which is based out of Cumberland Health.
- </c><00:40:03.760><c> health</c> when it comes to school-based health when it comes to school-based health
- Ibogaine puts 86% into remission.
- Ibogaine is neither of those.
- </c> therapeutic potential is unmatched. therapeutic potential is unmatched.
Keywords:
1. Call to Order and Roll Call – 00:00:00
2. Approval of Minutes – 00:01:32
3. Getting to Know the Foundation for a Healthy Kentucky – 00:02:26
4. Healthy Kids Clinic – 00:26:58
5. Pharmacy Payment Parity – 00:56:36
6. Ibogaine – 01:17:37
7. Consideration of Referred Administrative Regulations – 01:53:05
8. Adjournment – 01:53:19, 958, all
Summary:
The committee first approved the prior meeting minutes and recognized Eric Clark for his service, noting this may be his last meeting before he leaves state government. The main presentation was from Allison Adams, president and CEO of the Foundation for a Healthy Kentucky, who described the organization’s history, nonpartisan mission, and focus on health equity, prevention, and upstream policy solutions. She said Kentucky’s poor rankings in chronic disease, preventable hospitalizations, and life expectancy show the need to shift resources toward prevention and community-driven strategies rather than relying mainly on treatment after people become sick.
Adams emphasized leading health indicators, arguing that lawmakers should track actionable measures such as quit attempts and smoke-free policies instead of only lagging indicators like disease rates and mortality. In response to questions, she said accountability should be shared across communities and systems, with possible incentives and disincentives tied to outcomes, and she supported creating a public data utility or dashboard, ideally with university partners, to help legislators and communities monitor progress. She also cited examples of accountable health community models and said Kentucky could adapt similar approaches.
The committee then heard from Meade County Schools Superintendent Mark Martin and district health coordinator Karen Kotche about the Healthy Kids Clinic partnership with Cumberland Health. They described a seven-year effort that led to full implementation in the district, which now has a nurse in every school and a nurse practitioner, allowing services such as sports physicals and other clinic functions to be provided on campus. They said the program has been a strong investment for students and the community and began explaining how the district built the partnership after earlier efforts and delays, including the pandemic.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm
Joint Committee on Mental Health, Substance Use and Recovery
Transcript Highlights:
- The roadmap is all about investing in the community-based system, and if we can strengthen our community-based
- Now, ibogaine is not a cure-all.
- They were deeply therapeutic, sacred, and life-saving.
- They were deeply therapeutic, sacred, and life-saving.
- I don't have a particularly tragic, trauma-based backstory.
Summary:
The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback.
A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use.
The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care.
Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.
MO
Missouri 2026 Regular Session
2026 Legislative Session - Day Forty One - Wednesday, March 25 - Afternoon Session
Missouri House Floor Meeting
Transcript Highlights:
- Under this amendment, ibogaine includes ibogaine-based therapeutics, including ibogaine analogs.
- Under this amendment, ibogaine includes ibogaine-based therapeutics, including ibogaine analogs.
- Under this amendment, ibogaine includes ibogaine-based therapeutics, including ibogaine analogs.
- So they based it off of a hypothetical number.
- So I'm just going to read a little bit about ibogaine, ibogaine, in terms of whether we really want to
Summary:
The House convened, established a quorum, and welcomed special guests including the Freedom of the Road Riders and students from Warsaw High School. The chamber then took up House Committee Substitute for House Bill 1855, a reporting bill on alpha-gal syndrome. The sponsor described alpha-gal as a serious tick-borne condition affecting many Missourians, especially rural and outdoor workers, and argued that mandatory reporting would help the state track prevalence, identify hotspots, support physician education, and strengthen requests for funding. Supporters from both parties said the bill would improve public health data and help families who have struggled for years to get a diagnosis; one member raised concerns about cost and whether the data would be useful, but the bill sponsor said the fiscal impact was justified by the medical and economic burden of missed diagnoses. House Amendment 1, changing the department’s follow-up language from “may” to “shall,” was adopted, while House Amendment 2, which would have required patient consent before reporting, failed on a 41-10 vote. The committee substitute for HB 1855 was then adopted and ordered perfected and printed.
The House next considered House Committee Substitute for House Bills 2230 and 2978, a measure on school screen time and cursive/handwriting instruction. The sponsor said the bill was revised from a more prescriptive version into a research-based framework that creates a state-level focus group to study screen time’s effect on learning and to make recommendations, while also asking school districts to review policies and provide parents information about screen time. Supporters said excessive screen use has hurt literacy, behavior, and mental health, and that the bill gives local districts flexibility while moving schools toward evidence-based practices. Members raised questions about carve-outs for special education students and English language learners who rely on technology, and the sponsor said those concerns could be handled locally. An amendment to exclude the virtual school program was adopted, and the committee substitute for HB 2230 and 2978 was then adopted and ordered perfected and printed.
Finally, the House took up House Committee Substitute for House Bill 2355, the Food Is Medicine Initiative for Missouri. The sponsor said the bill would allow Missouri to use federal 1115 waiver funds for pilot programs that provide medically tailored meals, produce prescriptions, nutrition counseling, and related supports, arguing that food access is a preventive health tool that can reduce chronic disease and lower Medicaid costs. Supporters described food deserts and said the program could improve health outcomes and help families access healthier foods. An amendment adding cleanup language and allowing certain vitamin therapies was offered, but discussion focused on concerns about supplement quality and whether the amendment language was too broad. The transcript ends during debate on that amendment, before final action on HB 2355 is shown.
KY
Kentucky 2026 Regular Session
Senate Standing Committee on Health Service (3-11-26)
Transcript Highlights:
- </c> employed at military bases in Kentucky. employed at military bases in Kentucky.
- The 0.2% risk of death with ibogaine can be mitigated when ibogaine is administered properly.
- The FDA will not expect ibogaine to be 100% safe.
- I prepared to take my first dose of ibogaine.
- </c><00:35:52.640><c> benefits</c> uh does have some therapeutic benefits uh does have some therapeutic
Summary:
The committee first reviewed preferred administrative regulations and, hearing no concerns, considered them reviewed. It then took up House Bill 388, described as a Casper cleanup bill. The sponsor said it would exempt charitable health care providers from e-prescribing requirements, allow Casper data sharing with certain federal entities, update references to hydrocodone’s schedule status, clean up drafting errors, and clarify practitioner registration with Casper. The bill passed 9-0 and was then approved for consent.
Next, House Bill 134 was presented as a follow-up to a prior study on shortages of sexual assault nurse examiners and SANE-ready hospitals. The sponsor and a representative from the Kentucky Association of Sexual Assault Programs said the bill would create a statewide SANE coordinator. The committee adopted a substitute, then passed the bill unanimously and sent it to consent. Senate Bill 147 was then heard as an administrative update to vital records, modernizing certified-copy requests, adjusting fees, and requiring the Cabinet for Health and Family Services to send the annual death report to the State Board of Elections by July 1 each year. It passed unanimously and was also moved to consent.
House Bill 280, a Kentucky Board of Nursing cleanup bill, would let the board investigate out-of-state nurses applying for Kentucky licenses, clarify licensing language, and update school rescue medication provisions, including inhalers, nebulizers, glucagon, Solu-Cortef, and nasal epinephrine. A committee substitute narrowed the bill to glucagon updates, and one senator asked whether the bill also covered child care centers; the sponsor said it addressed school medications only but was open to further discussion. The bill passed 10-0 and was reported favorably.
Finally, Senate Bill 77 drew extended testimony. The sponsor and supporters argued that ibogaine research and treatment could help address addiction, PTSD, and depression, citing studies, personal recovery stories, and a proposed public-private partnership funded through opioid settlement money. The committee substitute removed the bill’s appropriation request and emergency clause, and members asked questions about whether PTSD is an addiction, whether smoking was included, whether the bill was authorizing research rather than funding, and how the treatment works. The sponsor said the substitute was only creating a structure for research, not appropriating money, and supporters described ibogaine as a one-time, medically supervised treatment. The transcript cuts off before a final vote on Senate Bill 77 is shown.
MO
Missouri 2026 Regular Session
2026 Legislative Session - Day Forty One - Wednesday, March 25 - Afternoon Session
Missouri House Floor Meeting
Transcript Highlights:
- It does not broadly legalize ibogaine in Missouri.
- Under this amendment, ibogaine includes ibogaine and ibogaine-based therapeutics, including ibogaine
- It also creates the ibogaine Intellectual Property Fund.
- So they based it off of a hypothetical number.
- So they based it off of a hypothetical number.
Summary:
The House first established a quorum, welcomed special guests, and then took up House Committee Substitute for House Bill 1855, a reporting bill on Alpha-Gal syndrome. The bill sponsor described Alpha-Gal as a serious tick-borne condition causing delayed allergic reactions and argued Missouri should track it through mandatory lab reporting to the Department of Health and Senior Services, with aggregated annual reporting to the CDC. Supporters said the measure would improve surveillance, identify hotspots, guide public health outreach, and help rural and agricultural communities that are heavily affected. An amendment changing the department’s follow-up language from “may” to “shall” was adopted after members said it would ensure accountability if the legislature funds the work. A second amendment seeking patient consent before reporting was debated at length over privacy and data concerns but failed 41-85, 10 present. The underlying bill then passed perfection and printing.
The House next considered House Committee Substitute for House Bills 2230 and 2978, a school policy bill focused on reducing K-5 screen time and encouraging handwriting and cursive instruction. The sponsor said the measure was revised to be less prescriptive, instead requiring school districts to review screen-time policies and creating a state-level “focus group” of educators, parents, and health professionals to study the issue and make recommendations. Supporters argued excessive screen use is linked to weaker literacy, behavior, and mental health outcomes, while some members raised concerns about technology use for special education students and English language learners. An amendment was adopted to exclude the virtual school program from the bill. The House then adopted the substitute and ordered it perfected and printed.
Finally, the House took up House Committee Substitute for House Bill 2355, the “Food is Medicine” initiative. The sponsor said the bill would let Missouri use federal 1115 waiver funds for pilot programs that provide medically tailored meals, produce prescriptions, nutrition counseling, and related nutrition supports for health care purposes. Supporters said the program could improve health outcomes, reduce Medicaid spending, and help address food deserts, while one amendment added vitamin therapies and updated a date in the bill. Members discussed concerns about supplement quality and the scope of covered therapies, but the bill advanced after the amendment debate.
MN
Transcript Highlights:
- </c> research base. research base. reading<00:07:20.319><c> intervention.
- </c> sustained, reliable sight-based sustained, reliable sight-based implementation<00:42:20.560><c>
- We know evidence-based instruction.
- field-based field-based um<00:59:38.559><c> work</c><00:59:38.799><c> as</c><00:59:39.040><c> part</
- c> Evidence-based mathematics standards and Evidence-based mathematics standards and practice.<01:14:
Bills:
HF3421
Keywords:
early literacy, reading instruction, teacher preparation, teacher candidates, teacher licensure, educator licensing, Professional Educator Licensing and Standards Board, PELSB, field experience, supervised practicum, evidence-based reading, science of reading, literacy methods, teacher training, preservice teachers, school-based experience, reading intervention, Minnesota education policy, 1183, house
TX
Texas 89th 2nd C.S.
Press Conference: Reproductive Rights Mar 18th, 2025
Transcript Highlights:
- expeditiously and concretely advance IBgain through the FDA's approval process as a breakthrough therapeutic
- The therapeutic efficacy of these treatments when administered in appropriate clinical settings under
- The scientific evidence supporting these emerging therapeutics continues to expand.
- Create regulatory frameworks for safe, supervised therapeutic administration.
- And 3 established pathways for insurance coverage for, excuse me, for approved therapeutic protocols.